{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:31:23Z","timestamp":1785007883532,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.07.019","type":"journal-article","created":{"date-parts":[[2007,8,2]],"date-time":"2007-08-02T11:27:04Z","timestamp":1186054024000},"page":"7233-7237","source":"Crossref","is-referenced-by-count":12,"title":["Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005"],"prefix":"10.1016","volume":"25","author":[{"given":"Mehmet","family":"Ceyhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inci","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Balmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouri","family":"Laher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nese","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysel","family":"Aydogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Ecevit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnar","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.07.019_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0264-410X(01)00410-8","article-title":"Vaccine prevention of meningococcal disease, coming soon?","volume":"20","author":"Morley","year":"2001","journal-title":"Vaccine"},{"issue":"24","key":"10.1016\/j.vaccine.2007.07.019_bib2","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMsb035678","article-title":"The meningococcal vaccine\u2013public policy and individual choices","volume":"349","author":"Offit","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2007.07.019_bib3","unstructured":"Hajjeh RA, Lingappa J. Meningococcal disease in the Kingdom of Saudi Arabia: an evaluation of disease surveillance and control after an outbreak of serogroup W-135 meningococcal disease. CDC Report. June 30\u2013July 23 2000;1\u201321."},{"issue":"10","key":"10.1016\/j.vaccine.2007.07.019_bib4","first-page":"1410","article-title":"Changes in epidemiological pattern of Meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control?","volume":"25","author":"Al-Mazrou","year":"2004","journal-title":"Saudi Med J"},{"key":"10.1016\/j.vaccine.2007.07.019_bib5","first-page":"431","article-title":"Incidence of epidemiological meningitis in Agean region","volume":"4","author":"Coskun","year":"1990","journal-title":"Turk J Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.019_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.47102\/annals-acadmedsg.Gazi","article-title":"Oropharyngeal carriage and penicillin resistance of Neisseria meningitidis in primary school children in Manisa, Turkey","volume":"33","author":"Gazi","year":"2004","journal-title":"Ann Acad Med Singapore"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.019_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3201\/eid1005.030572","article-title":"Neisseria meningitidis W135, Turkey","volume":"10","author":"Doganci","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.019_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1128\/JCM.44.1.222-224.2006","article-title":"Clonal spread of serogroup W135 meningococcal disease in Turkey","volume":"44","author":"Kilic","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2007.07.019_bib9","series-title":"Requirements for meningococcal polysaccharide vaccine. World Health Organization technical report series, no. 594","year":"1976"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.019_bib10","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. 1. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.019_bib11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.07.019_bib12","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0264-410X(02)00630-8","article-title":"Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era","volume":"21","author":"Trotter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.07.019_bib13","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3201\/eid1010.040335","article-title":"Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America","volume":"10","author":"Pollard","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.019_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1017\/S095026889900285X","article-title":"Antimeningococcal herd immunity in the Czech Republic\u2014influence of an emerging clone, Neisseria meningitidis ET-15\/37","volume":"123","author":"Kriz","year":"1999","journal-title":"Epidemiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.019_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.019_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/CDLI.11.2.272-279.2004","article-title":"Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135","volume":"11","author":"Lal","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.07.019_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/CDLI.2.2.132-137.1995","article-title":"Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference","volume":"2","author":"Holder","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.019_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CDLI.11.1.1-5.2004","article-title":"Assignment of Neisseria meningitidis serogroup A, C, W135 and Y anticapsular total IgG, IgG1 and IgG2 concentrations to reference sera","volume":"11","author":"Joseph","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2007.07.019_bib19","series-title":"Meningococcal vaccines: methods and protocols","author":"Pollard","year":"2001"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.019_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CDLI.11.1.83-88.2004","article-title":"Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A\/C polysaccharide vaccination in Saudi Arabia","volume":"11","author":"Jokhdar","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.019_bib21","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/IAI.13.6.1654-1662.1976","article-title":"Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide","volume":"13","author":"Vann","year":"1976","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.019_bib22","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1084\/jem.162.6.1837","article-title":"Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies","volume":"162","author":"Guirguis","year":"1985","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.019_bib23","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/IAI.73.5.2932-2939.2005","article-title":"Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age","volume":"73","author":"Al-Mazrou","year":"2005","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2007.07.019_bib24","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/CDLI.12.10.1251-1253.2005","article-title":"Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age","volume":"12","author":"Khalil","year":"2005","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07008110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07008110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T06:17:36Z","timestamp":1708150656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07008110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":24,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07008110"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}